Navigation Links
BMP Sunstone Reports First Quarter 2009 Financial Results
Date:5/18/2009

ds) March 31, December 31, 2009 2008 Assets Current Assets: Cash and Cash Equivalents $21,251 $15,740 Restricted Cash 781 1,150 Notes Receivable 18,776 15,797 Accounts Receivable, net of allowance for doubtful accounts of $210 and $127 38,254 30,897 Inventory, net of allowance for obsolescence of $45 and $0 9,570 10,184 Due from Related Party 2,435 1,834 Other Receivables 2,189 2,168 VAT Receivable 989 921 Prepaid Expenses and Other Current Assets 5,181 6,247 Total Current Assets 99,426 84,938 Property and Equipment, net 23,999 22,840 Investment in Alliance BMP Limited 15,093 15,093 Investment in Shengda 2,938 -- Investments, at Cost 146 146 Goodwill 69,950 69,866 Other Assets 716 875 Land Use Rights, net of accumulated amortization 1,983 2,002 Intangible Assets, net of accumulated amortization 41,107 41,891 Total Assets $255,358 $237,651 Liabilities and Stockholders' Equity Current Liabilities: Notes
'/>"/>
SOURCE BMP Sunstone Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. BMP Sunstones Propess(R) Recommended as First Line Treatment By the Chinese Medical Association
2. BMP Sunstone to Report First Quarter 2008 Financial Results
3. BMP Sunstone Announces Participation in May Investor Conferences
4. BMP Sunstone Donates RMB 1.2 Million to Earthquake Relief
5. BMP Sunstone Reports First Quarter 2008 Financial Results
6. BMP Sunstone Announces Participation in June Investor Conferences
7. BMP Sunstone Announces Official Launch of Ferriprox in PRC
8. BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd
9. BMP Sunstone Signs Letter of Intent to Acquire Shengda Pharmaceutical Co.
10. BMP Sunstone to Report Third Quarter 2008 Financial Results
11. BMP Sunstone Announces Exchange Offer of $10.7 Million of Outstanding Secured Notes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ommunications announces a highly effective and unc...truggling to make an economic recovery. , ...fears is the type of challenge that could send ail... to Dr. David Benton, business growth expert and a... – The Rfactor Intensive . “Fear is...
(Date:11/25/2009)...wswire/--TheBartleHallConventionCenterwilltemporar...,whenKansasCityhoststhelatestinaseriesofmassivefre...venthasthepotentialtobethebiggestoneyet,becauseitw...kdaysinsteadofoveraweekend,"SheriWood,executivedir...theNationalAssociationofFreeClinics(NAFC). ,, A...
(Date:11/25/2009)...-SentinelleMedicalInc.,aleadingmanufacturerofbreas...suiteofnewleadingedgeclinicalapplicationsonitsAegi...iologicalSocietyofNorthAmerica(RSNA)annualmeetingi...licationsleveragetheuniquehighqualityimagesgenerat...rtmultipleimagingmodalitiesformulti-parametricasse...
(Date:11/25/2009)...re-USNewswire/--TheBlackAIDSInstituterecentlyheldB...hipfor2010. ,, ThenewBoardMembersareahighlydive...,finance,governmenthealthprograms,editorial,andbus...ngeofpersonalbackgroundsincludingbothheterosexuala...andrepresentingmultipleagegroups. ,, (Photo: ht...
(Date:11/25/2009)...r cancer who were treated with cisplatin-based che...neurological side effects and Raynaud-like phenome...y, according to a new study published online Novem...itute . , Marianne Brydy, M.D., of the Departmen...ergen, Norway, and colleagues conducted a cross-se...
Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2
... a recent study conducted by researchers at Wake F...gues show that cognitive functioning abilities dro...h type 2 diabetes. , The study appears in this mo...rial (ACCORD), found a statistically significant i...
...French . , Montreal, February 11th, 2009 - The ...nt on the nutrients the tumours receive through th...ch Institute of the McGill University Health Centr... stimulate the growth of the blood vessels that fe...
...rld,s first phase one FDA-approved clinical trial ...ase will be conducted by a team of University of ...he first time, patients with advanced heart diseas...ent,s own cardiac tissue. During surgery, a small ...
... Abbott ( NYSE: ABT ),today announced it received...nistration (FDA) for its new, compact hematology i...N Emerald will expand the company,s hematology,pla...ries and clinics continue to seek,greater efficien...
...ges Prevention Through Screenings , ...-- What better time than February, National Cancer...r health is in their own hands? ZocDoc, the servic... month. Now more than ever, New Yorkers are able t...
...ves better predictor than PSA, study says , ...g for changes in the number of circulating tumor c...ostate cancer patients, survival and response to t...ors such as changes in levels of prostate-specific...
Other Medicine News:Health News:Higher blood sugar levels linked to lower brain function in diabetics, study shows 2Health News:Innovative method to starve tumors 2Health News:World's First Cardiac Adult Stem Cell Trial to Take Place in Louisville 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 2Health News:Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument 3Health News:ZocDoc Joins the Fight Against Cancer 2Health News:Levels of Circulating Tumor Cells Could Predict Prostate Cancer Outcome 2
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--RegadoBiosciences,aprivat...captamerswithactivecontrolagents,announcedthatDavi...perJaffray21stAnnualHealthCareConferenceattheNewYo...illbegivenat1:10pm(EST)onTuesday,December1andwilli...ontheleaddevelopmentprogram,theanticoagulantsystem...
(Date:11/25/2009)...5/PRNewswire/--Reportlinker.comannouncesthatanewma... MammographyEquipment-AGlobalMarketPerspective ...graphy-Equipment---A-Global-Market-Perspective.htm...izedaswellasdevelopingnationsisaprincipalfactorinf...latingawarenessaboutbreastcancerhasallowedwomentoc...
(Date:11/25/2009)...,Nov.25/PRNewswire/--AccordingtoMillenniumResearch...rketintelligence,thenearly$3billionUSmarketfortrau...henextfiveyearsdespitetherecenteconomicslowdown.MR...tthismarketwillremainhighlydynamicoverthenextfivey...npreviouslyunderservedsegmentsofthetraumafixationm...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Indiana University receives NIH grant to improve health care in East Africa 61442 1Indiana University receives NIH grant to improve health care in East Africa 61442 2Indiana University receives NIH grant to improve health care in East Africa 61442 3Scientists guide immune cells with light and microparticles 10745 1Scientists guide immune cells with light and microparticles 10745 2New research provides insights into potential ecological costs and cobenefits of REDD 10742 1New research provides insights into potential ecological costs and cobenefits of REDD 10742 2New research provides insights into potential ecological costs and cobenefits of REDD 10742 3
... -, PRINCETON, N.J. and SAN DIEGO, Aug. 18 Tobir...y company committed to the,research and product di...,infectious diseases, today announced the issuance... Trademark Office, covering the use of TBR-652, a,...or the treatment of HIV-1,infection in adults., T...
...Newswire-FirstCall/ -- Pharmaxis,(ASX: PXS; Nasdaq...se 3,clinical trial of Bronchitol for the treatmen...e first efficacy data from the trial is expected t...trial commenced its dosing phase in,April 2007, re...ts in June,2008 and closed today with 325 subjects...
Other Medicine Technology:Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2
...matology control, offers complete assay values for...ith the Coulter GENS, STKS, MAXM and HmX. This uni...y closed-vial stability and is available in low, n...al is compatible with all cassette systems. Barcod...
Antelys Peek Lumbar Technologies
D-SPECT Cardiac Imaging System
Placemark
Medicine Products: